Stryker’s Q Guidance System Scores FDA Clearance For Cranial Applications
Stryker Corporation (NYSE:SYK) announced that its Q Guidance System with Cranial Guidance Software received FDA510(k) clearance. The Q Guidance System…
General Motors, Bank of America And 2 Other Stocks Insiders Are Selling
The Nasdaq dropped by more than 100 points on Monday. Investors, meanwhile, focused on some notable insider trades.
Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session.
Wells Fargo Maintains Overweight on Stryker, Raises Price Target to $285
Wells Fargo analyst Larry Biegelsen maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $281 to $285.
Loop Capital Maintains Buy on Stryker, Raises Price Target to $290
Loop Capital analyst Jason Wittes maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $245 to $290.
BTIG Maintains Buy on Stryker, Raises Price Target to $281
BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $268 to $281.
Canaccord Genuity Maintains Hold on Stryker, Raises Price Target to $250
Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Hold and raises the price target from $220 to $250.
Truist Securities Maintains Hold on Stryker, Raises Price Target to $275
Truist Securities analyst Richard Newitter maintains Stryker (NYSE:SYK) with a Hold and raises the price target from $257 to $275.
Piper Sandler Maintains Overweight on Stryker, Raises Price Target to $280
Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $250 to $280.
Stryker Q4 Adj. EPS $3.00 Beats $2.84 Estimate, Sales $5.20B Beat $4.96B Estimate
Stryker (NYSE:SYK) reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.84 by 5.63 percent. This is a 10.7 percent increase over earnings of $2.71 per share from the same period